Scientists seeking to unlock secrets of cellular ageing have identified a gene that triggers senescence, a phenomenon in which cells stop dividing.
Disruptive science can have a significant impact outside of our own domains of research and into our personal lives. Keeping abreast of these developments can help prepare and inspire.
Psychiatric disorders share many genetic variants, while neurological disorders appear more distinct, according to a new study from the Brainstorm Consortium.
A survey of people who have taken part in clinical trials indicates that participants care more about the benefits to science than the risk of sharing their personal data.
The U.S. Patent and Trademark Office has decided to grant not just one, but two new CRISPR patents to UC Berkeley, home of pioneer Jennifer Doudna, who many consider the creator of the technology.
The Wellcome Sanger Institute has provided evidence and made recommendations for an inquiry by the UK Parliament Science and Technology Committee into an immigration system that works for science and innovation, following Brexit.
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
Researchers have found that by helping to form clots within tumours, immune cells that flock to a particular type of lung cancer are actually building a foundation for the tumour to spread within the body.
Researches have identified molecular features of testicular germ cell cancers that could inform future efforts to improve treatment decisions and help monitor patients to see if their cancer has come back.
George Church talks about his disappointment with the Human Genome Project, the blistering price/performance improvements in both DNA synthesis and sequencing, and CRISPR’s strength and weaknesses, in addition to the improvements he hopes to see in its successors.
A new technique, dubbed intron seqFISH enables scientists to image 10,421 genes at once within individual cells.
Leading cancer and gene therapy scientist, Inder Verma, has resigned from the Salk Insitute for Biological Studies in San Diego, California.